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Parkinson’s Disease gained notoriety in a Hollywood blockbuster film 
adaptation of Oliver Sacks’s Awakenings, starring Robin Williams and Robert 
de Niro. Sack’s 1973 book and the 1990 film, presented an account of 
survivors of the 1914-1924 encephalitis lethargica epidemic waking up from 
a catatonic state following large doses of L-Dopa.1 In a particularly poignant 
moment in the movie, De Niro’s character, Leonard Lowe, dances away his 
pathological muscle rigidity and spasms with his darling Paula. Sadly 
Leonard Lowe, like the non-fictional patients who experienced this moment 
in medical history, returns to his catatonic state but the idea of dance as a 
cure for symptoms of Parkinsonism has survived and is a subject important 
to the present article.2 
In a book on Musicophilia in 2007, Oliver Sacks subsequently 
proposed that in fact musical rhythm may have a primal function in the 
brain which modern science is yet to fully explain.3 Sacks illustrates his 
arguments with accounts of patients in 2007 with various types of frontal 
lobe lesions, such as Frontal Lobe Dementia, Alzheimer’s and some 
Parkinson’s Disease who developed new aptitudes for musical creativity 
after the onset of their disease. This led Sacks and others to speculate that 
creative inhibition was genetically coded into frontal lobe function and was 
disengaged through some pathological lesions which, so to speak, let the 
music out.4 
 In Sacks’s captivating narratives neurological changes and creativity 
are tales of transformation brought about by illness. In When Walls Become 
Doorways (2006) Tobi Zausner recounted similar patients’ narratives who 
experienced creative moments in their lives following illness such as the 
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Oliver Sacks’s discussion of dance therapy at Beth Abraham Hospital and 
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3 Ibidem. 





artist Henri Matisse.5 Patient narratives do not have a prerogative, however, 
on defining and interpreting the relationship between illness and creativity. 
This is acutely the case for sufferers of neurological degeneration that brings 
about the assemblage of disorders that continue to be identified as 
Parkinson’s Disease even though that terminology is itself challenged by the 
historical scientific and clinical tradition that created it.  
This essay investigates how and why two cultural interpretations of 
the relationship between creativity and Parkinson’s Disease have developed 
and changed over time. It interrogates the historical determinants of a 
neuro-psycho-biological discourse with the power to affect human 
consciousness and somatic experience through pharmacological 
manipulation according to its own edicts. The paper contrasts this discourse 
with Parkinson’s Disease patients’ narratives of the transformative affect of 
creativity allowing them to experience different ways of becoming human. 
The paper argues that the two counter cultures of creativity and Parkinson’s 
Disease have been framed by a pivotal historical moment in which two 
critically significant changes occurred in the epistemological status and 
causal explanation of Parkinson’s Disease. Firstly, when the ontology of 
Parkinson’s Disease as a single entity became dispersed into a set of 
emergent interactions over a human life-course including risks of getting the 
disease and pre and post-diagnostic behavioral pathologies. Secondly, when 
neuroscientific investigation achieved this ontological dispersal through the 
explosion of the causal explanation of Parkinson’s Disease as a motor 
disorder which was caused by the death of neurons in the brain that 
produce the neurotransmitter, dopamine. Finally the paper argues that 
contrasting representations of the relationship between being and becoming 
characterize the two historical cultural interpretations of the relationship 
between Parkinson’s Disease and creativity. The paper demonstrates the 
historical rise of a clinical diagnosis of creativity in Parkinson’s patients as a 
pathological symptom and the contrasting narrative of Parkinson’s patients 
for whom creativity is an opportunity of experiencing a new way of what it 
means to be human. In the neuro-psycho-biological discourse the 
replacement of static ontology (being) with temporal emergence (becoming) 
has not eliminated reductionist reasoning about the relationship between 
creativity and disablement. The paper argues that a different epistemology 
of being and becoming is evident within patient narratives of the 
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transformative affect of creativity represented in the understanding and the 
experience of human variety. 
 
 
Neuroscience troubles ontology: exploding the Nigrastriatal 
Dopamine-Deficiency Paradigm of a Motor-Disorder. 
 
Since 2008 The Jack Clark Professor in Parkinson’s Disease Research at the 
University of Toronto (and Director of the Shulman Movement Disorder 
Clinic at Toronto Western Hospital), Anthony Lang, has been urging the 
clinical world to face up to the fact that there is no Parkinson’s Disease but 
many manifestations of multiple aetiological syndromes with what 
historians might refer to as customs in common.6 The discovery of multiple 
neuro-pathogenerative pathways resulting in motor and non-motor 
symptoms associated with Parkinson’s has led Lang to identify the dawn of 
a new era in the clinical profile of what has until relatively recently been 
understood as a single nosology. What causes Lang to come to these 
conclusions is novel molecular understanding of neurodegeneration which 
has undermined the aetiological paradigm of nigrostriatal dopamine 
deficiency7 and the decentralisation of motor disorder in the clinical profile 
of Parkinson’s Disease (PD).8  
A full historical account of the assembling of the nigrastriatal 
dopamine deficiency PD paradigm has been undertaken in another paper.9 
In this essay I am going focus on the historical process in which a clinical 
category of a Parkinson’s patient personality was constructed and the 
pathologicalization of creativity within that paradigm. 
                                                     
6 B. Patoine, ‘Facing Up to the ‘New Face’ of Parkinson’s Disease. An Interview 
with Anthony E. Lang’, The Dana Foundation (2012) 1-3. 
7 See Fig 1: Dopamine Pathways in the Brain 
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Experimentation by the Professor of the Nobel Prize winner Arvid 
Carlsson at Lund University in the 1950s proved that the cause of 
Parkinson’s Disease was the loss of dopamine in the brain. He 
demonstrated this causal relationship by using a neuroleptic drug, reserpine, 
to suppress dopamine in the brains of rabbits which made them catatonic. 
He revived the rabbits by injecting them with a large dose of the amino acid 
dopa proving that dopamine in the area of the brain known as the basal 
ganglia was responsible for determining physical motor control in the body.  
 
The role of dopamine in behaviour, however, became an inevitable 
deduction once Carlsson had established the effect of behavioural drugs in 
suppressing dopamine release. Thus psychopathology must be the result of 
excessive dopaminergic activity.10 The dopamine hypothesis of 
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Fig. 1: ‘The Dopamine 
Pathways in the Brain’, CNS 
Forum, Lundbeck Institute, 









psychopathology became established and was contested throughout the 
latter half of the twentieth century but the dopamine system in the brain 
became definitively central to genomic research on cognition and emotional 
variation from the 1990s.11 The role of the DA, that is dopamine molecules 
in the brain, system in cognitive and emotional variability, however, was 
given an entirely new profile with the development of Tridimensional 
Temperament System developed in the 1980s and 1990s by the Kantian 
transcendentalist philosopher-professor of psychiatry at Washington 
University, Claude Robert Cloninger.12 In 1986 Cloninger argued in what he 
called a ‘Unified Biosocial Theory of Personality’ that heritable personality 
traits of novelty seeking, harm avoidance and reward dependence were 
correlated with dopaminergic activity in the basal ganglia, serotonergic 
activity and basal noradrenergic activity.13  
The Tridimensional Temperament System provided a new 
methodological and epistemological framework for genomic correlation 
with personality and cognitive analysis.14 Cloninger first developed his 
methodologies for developing predictive personality models when working 
in Sweden in the 1980s on alcohol dependence through ‘separation studies’, 
i.e. investigating cohorts of adopted children separated from their biological 
parents at birth.15 By the end of the decade he codified his pyschobiological 
temperament model in a Tridimensional Personality Questionnaire (TPQ) 
and a Tridimensional Character Inventory (TCI).16 These tools provided the 
                                                     
11 D. Ball et al., ‘Dopamine Markers and General Cognitive Ability’, Neuroreport 9 
(1998) 347-349; S. Nakajima e.a., ‘The Potential Role of D3 Receptor 
Neurotransmission in Cognition’, European Neuropsychopharmacology 23.8 (2013) 799-
813.  
12 G. Hellinga e.a., ‘Robert Cloninger’ in: J. Aronson ed., Personalities: Master 
Clinicians Confront the Treatment of Borderline Personality Disorder (Northvale and London 
2001) 99-120. 
13 C.R Clonginger, ‘A unified biosocial theory of personality and its role in the 
development of anxiety states’, Psychiatry Developments 1986 4.3 (1986) 167-226. 
14 Ibidem. 
15 E.J. Devor and C.R. Cloninger, ‘Genetics of Alcholism’, Annual Review of Genetics 
23 (1989) 19-36. 
16 C.R. Cloninger e.a., ‘The Tridimensional Personality Questionnaire: U.S. 
Normative Data’, Psychological Reports 69 (1991) 1047-1057; idem, ‘A 
Psychobiological Model of Temperament and Character’, Archives of General 





neurobiology of cognition and character with a new methodological 
framework of investigation.  
Cloninger’s dopaminergic hypothesis of character and temperament 
facilitated investigations into the genomic influence on dopamine 
dependent cognitive and emotional variation. From the earliest studies with 
twins a discourse on the inheritability of cognitive ability has been 
embedded in the psychobiology of intelligence.  
 
 
Since the completion of the human genome map the role of the 
dopaminergic system (DA) and its genetic variations have reframed this 
investigation. Candidate dopaminergic genes in cognitive variation that have 
been explored so far include catechol-0-methyltransfrerase (COMT)17 and 
                                                                                                                       
and Character Inventory – Revised in a Belgian Sample’, Journal of Personality 
Assessment 85 (2005) 1931-1946. 
17 A gene that codes for dopamine. 
Fig. 2: Paul Richer: Figurine: 
‘Parkinson’s Disease’ (cc. 
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some of its nucleotide polymorphisms18 related to prefrontal executive 
functioning in processes such as attention and working memory. COMT is 
an enzyme which plays a crucial role in the metabolism of the 
catecholamines by inactivating them in the synaptic cleft. Another candidate 
gene for intelligence that has been significantly investigated has been the D2 
receptor gene (DRD2) and one of its polymorphic regions, DRD2 TAQ 
1A.19  
D2 receptor polymorphisms have also become central to genomic 
investigations of a subset of cognitive function, creativity, since the mid-
2000s. Dopaminergic variation currently occupies the central focus of the 
neuromolecular gaze upon creativity defined and measured as levels of 
novelty seeking divergent thought using Cloninger’s Tridimensional 
Character and Temperament System. Mesolimbic accounts of creativity 
have now gained sufficient confidence to begin claiming the capacity to be 
predictive. For example, Sapra, Beavin and Zak from Claremont Graduate 
University and Loma Linda Medical School in California recently claimed to 
have demonstrated what they believe is the gene-combo that produces 
successful careers amongst the top socio-economic 1% in their recent 
PLOS article on ‘A Combination of Dopamine Genes Predicts Success by 
Professional Wall Street Traders’.20 
Apart from facilitating the genomic investigation of heritable 
cognitive creativity variation Cloninger’s Tridimensional Character and 
Temperament System has also been utilized in the genetic investigation into 
emotional variation.  
The investigation into genomic variation in creativity centers upon 
the correlation of activity in the dopaminergic pathway in the brain that 
deals with reward learning, novelty seeking and pathological addiction with 
temperament and personality characteristics measured by the 
Tridimensional Temperament System.21 This has had an emphatic influence 
                                                     
18 The polymorphisms of the gene. 
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Functioning: A Molecular Genetic Approach’, Behavioral Brain Research 164 (2005) 
93-99; Idem, ‘Identification of first candidate genes for creativity: A pilot study’, 
Brain Research 1069 (2006) 190-197.  
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on the neuromolecular construction of a pre-morbid Parkinson’s patient 
personality. 
In 1913 Carl Dudley Camp22, by then Clinical Professor in Nervous 
Diseases appointed at the University of Michigan posited that:  
 
It would seem that paralysis agitans affected mostly those persons 
whose lives had been devoted to hard work (…) The people who 
take their work to bed with them and who never come under the 
inhibiting influences of tobacco or alcohol are the kind that are most 
frequently affected. In this respect, the disease may be almost 
regarded as a badge of respectable endeavor.23 
 
One hundred years of psychobiology have subsequently characterized 
Parkinson’s patients as possessing distinctive personality traits of 
industriousness, seriousness and inflexibility. Cloninger’s Tridimensional 
Character Framework has re-scripted this clinical/anecdotal epistemological 
system profoundly. The TPQ and TCI have become the major 
methodological tools for investigating a pre-morbid Parkinson’s personality 
as a predictive device not only for determining predilection to the onset of 
motor-dysfunction but of progressive cognitive and behavioral 
transformation. 24 
                                                                                                                       
personalities and polymorphism of dopamine D2 receptor among heroin addicts’, 
Biological Research For Nursing 14.2 (2012) 188-196; S.W. Savage e.a., ‘Regulation of 
novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in 
obesity’, Obesity (Silver Spring). 11 (2014). 
22 R.N. Dejong, ‘Carl Dudley Camp’, Journal of Nervous and Mental Disease 122.1 
(1955) 116. 
23 C.D. Camp, ‘Paralysis Agitans, Multiple Sclerosis and their Treatment’ in: W.A. 
White, S.E. Jelife and H. Kimpton ed., Modem Treatment of Nervousand Mental Disease 
2 (Philadelphia 1913) 651-667; See also: C.T. Todes and A. J. Lees, ‘The Pre-morbid 
Personality of Patients with Parkinson’s Disease’, Journal of Neurology, Neurosurgery 
and Psychiatry 48 (1985) 97-100; L. Ishihara, and C. Brayne, ‘What is the evidence for 
a pre-morbid Parkinson’s Personality: A Review’, Movement Disorders 28.8 (2006) 
1066-1072.  
24 See for example: R. Tomer and J. Aharon-Peretz, ‘Novelty seeking and harm 
avoidance in Parkinson’s disease: effects of asymmetric dopamine deficiency’, 
Journal of Neurology, Neurosurgery and Psychiatry 75 (2004) 972-975; G. Pluck and R.G. 
Brown. ‘Cognitive and Affective Correlates of Temperament in Parkinson’s 
Disease’, Depression Research and Treatment (2011). For critique of use of TPQ and 





In 1993 Matthew Menza and colleagues from the Robert Woods 
Johnson Medical School at the University of Medicine and Dentistry New 
Jersey identified dopamine-related personality traits in Parkinson’s disease 
using Cloninger’s Tridimensional Personality Questionnaire. Menza e.a. 
claimed that low novelty seeking Parkinson’s patients were reflective, stoic, 
slow-tempered, frugal, orderly and persistent. They were by contrast high 
scoring on Harm Avoidance. In 1995 the Menza team claimed to explain 
this correlation by confirming through PET scans of PD patients that low 
18 F-Dopa (i.e. Radioflurinated Dopamine) striatal uptake correlated with low 
novelty scores.25  
Subsequent studies such as those of Valterri Kaasinen e.a. from the 
University of Turku in Finland argued that Menza’s results could simply be 
demonstrating the effects of long-term medication on advanced PD 
patients. But nevertheless, the neuromolecular pursuit of the predisposed 
PD low-creative, harm avoiding, fearful dullard has continued up to the 
present.26 In 2011 Grahame Pluck and Richard Brown from Sheffield 
University and Kings College London attempted to extend the 
temperament model of predisposed PD personality through a study on 
cognitive attention capacity. Using the Cloninger epistemological and 
methodological framework Pluck and Brown claimed to have demonstrated 
characteristic apathy in PD patients that is unrelated to the affective 
disorders of depression and anxiety associated with the disease. They 
claimed instead that high apathy scores are correlated with characteristic 
cognitive function of the pre-morbid Parkinson personality. Pluck and 
Brown legitimize their claims by using historical studies confirming the 
existence of a pre-morbid Parkinson’s personality stretching back to 
Charcot describing the low motivation in PD patients.27 
                                                                                                                       
with Parkinson’s disease: assessment and clinical implications’, Journal of Neurology 
259.6 (2012) 1029-1038. 
25 M.A. Menza e.a., ‘Dopamine-related personality traits in Parkinson's disease’, 
Neurology 43.3.1(1993) 505-508; idem, ‘Personality correlates of [18F]dopa striatal 
uptake: results of positron-emission tomography in Parkinson's disease’, The Journal 
of Neuropsychiatry & Clinical Neuroscience 7.2 (1995) 176-179. 
26 V. Kaasinen e.a., ‘Personality traits and brain dopaminergic function in 
Parkinson’s disease’, Proceedings of the National Academy of Science U.S.A. 98.23 (2001) 
13272-13277. 
27 G. Pluck and R.G. Brown, ‘Cognitive and Affective Correlates of Temperament 





Poor Parkinson’s patients. Under the neuromolecular gaze PD 
patients are dogged by dopamine and never to be released. As Genevieve 
Aubert has pointed out the neurological patient has been studied and 
documented extensively through visual media.28 The Parkinson’s patient has 
been clinically visualized by Charcot’s drawings of the propulsive and 
retropulsive gait which fascinated him and by Samuel Wilson’s documentary 
films of patients at the Queens Square Neurological Institute in the 1920s 
and by contemporary MRI videos of dopaminergic activity in the brain.29   
But perhaps the most emblematic representation of the Parkinson’s 
patient is the frail, broken, pitiful figure depicted in a figurine by Paul 
Richer, Charcot’s collaborator in the 1880s. Richer’s image is an archetype 
of somatic degeneration vividly, sculptured into the imagination.30 The 
stigmata of pitiful objectification of this pathetically broken creature is 
inescapably overwhelming.31 
In this section I have tried to demonstrate how dopaminergic 
molecular-neuorogazing has prescribed inevitable destiny upon Richer’s 
pitiful object. According to the dopaminergic neuromolecular gaze, Richer’s 
figure was determined by dopaminergically coded inflexibility, stoicism, 
harm avoiding logic and dullard low creativity. According the genomic and 
psychobiological modeling of the Parkinson’s personality, temperamental 
rigidity defines the Parkinson’s patient long before he has any physical 
bracykinesia. And their predisposition to inhibited personality is inscribed as 
emphatically in their genetically determined lack of novel imagination as it 
becomes in their cogwheel motor movements and pill-rolling tremors. 
In the next section of the paper I interrogate the history of how 
subsequent discovery of creativity in Parkinson’s patients became 
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pathologized according to the neuro-psycho-biological paradigm of a 






According to neuromolecular biopsychological theory, when genetically 
predisposed uncreative Parkinson’s personalities demonstrate creativity it is 
a pathological symptom. A body of neurobiological and clinical 
observations articulated over the last decade has identified creativity in 
Parkinson’s patients as another form of pathological disability.  
In 2001 Anette Scharg, MD. PhD and Michael Trimble MD from 
University College London reported what they believed to be the first case 
of poetic talent being ‘unmasked’ by dopamine agonist treatment for 
Parkinson’s.32 Their patient was aged forty when he was first diagnosed with 
Parkinson’s having a tremor in his left hand, dragging his left leg, and 
dystonia of the left foot. As symptoms increased the patient started 
treatment with the dopamine agonist lisuride and levadopa at age 44. His 
symptoms significantly improved and within the first month of treatment he 
began writing poetry for the first time in his life completing ten poems in 
the first year of treatment. His poems achieved significant publishing 
success and he won a prize in the annual contest of the International 
Association of Poets.33 
The patient had always considered himself intellectually inferior to 
his siblings and family generally never having achieved an equivalent level of 
academic success. He did, however, have a maternal grandfather who was a 
published poet and he was related to a well-known Irish poet. No other 
changes occurred until after twelve years of treatment the patient began to 
show symptoms of depression, aggressive and volatile behavior along with 
grandiose ideas, paranoid delusions, extreme circumstantiality, 
overtalkativeness and pressured speech. After various therapeutic 
adjustments the patient returned to a stable emotional and cognitive state, 
with sustained control of motor symptoms. Throughout this period and to 
the end of his life the patient continued to write and publish his poetry. 
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Scharg and Trimble explored a wide range of possible explanations for their 
‘poet unmasked’ including contradictory implications of the classic ‘pre-
morbid PD personality theory’ but found none sufficiently satisfactory. 
They finally concluded that they could only speculate that the effect of 
dopaminergic and serotomergic drugs, either through cognitive 
enhancement, increased perception or a hypomanic syndrome in addition to 
selective frontocortical dysfunction, led to the release of previously 
inhibited creative power in this patient.34 
If Scharg and Trimble were only tentatively speculating that perhaps 
their patient’s art was a sort of hypomanic ‘high’ by the mid 2000s a more 
reductive neuropsychological explanation was being offered of PD visual 
art. In 2005, Ruth Walker and colleagues at the Veterans Affairs Medical 
Center New York and NYU School of Medicine described a patient who 
had possessed pre-morbid undeveloped ‘artistic tendencies’ for sketching 
that dramatically changed seven years after beginning dopamine agonist 
therapy.35 At this point he started producing several pastel drawings a week 
– sometimes two a day. After moving to an assisted living facility he had 
even more time to devote to his art but at the same time began to show 
hypersexual disinhibition in what they describe as ‘excessive flirting with 
women on the street and asking residents and staff of his assisted living 
facility to pose nude for his artwork’. 36 His disinhibition became controlled 
following what they describe as ‘education’ and his artwork began to be 
shown and sold in local galleries in the Bronx. In contrast to Schrag and 
Trimble, Walker e.a. describe their patient’s artistic productivity as a 
pathological symptom of compulsive disorder equivalent to pathological 
gambling and hypersexuality associated with excessive dopamine 
stimulation. Thus, the Walker team identified their patient’s creativity as the 
result of the overstimulation of the third dopaminergic pathway in the brain 
which is responsible for reward learning that can become pathologically 
transformed into addiction.37 
In 2006 Anjan Chatterjee, Roy Hamilton and Prin X. Amorapanth 
from University of Pennsylvania were far more reluctant than the Walker 
team to ‘reduce CSF’s [their patient] art to the ravages of PD’ even after 
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considering the pros and cons of defining it as an obsessive compulsive 
disorder.38 CSD, the Chatterjee team’s patient, was a 68 year old graphic 
designer whose motor symptoms had progressed over 15 years from 1992 
while his agonist and Levadopa medications had been adjusted to 
compensate. A psychologist encouraged CSD to start painting as a 
therapeutic activity to relieve his depression in 2002. While initially 
producing work derivative of Van Gogh within a year he had begun 
producing uniquely original vibrant colored pencil abstract works using fine 
regular lines. He used his right hand in which his resting tremor was severe 
enough to significantly restrict his capacity to write. But his artistic work 
used large amplitude proximal movements [reaching rather than distal 
movements used in writing and grasping] that allowed him to feel ‘a sense 
of bursting forth and tearing back walls’. CSD expressed an urgency to 
produce and utilized the sleep disruption produced by PD to awake early 
and get to work. His complete immersion into a visual image prevented 
him, he noted, however from working on more than one painting at a time. 
While Chatterjee e.a. note that CSD’s preoccupation with his art could be 
interpreted as a compulsive obsessive disorder equivalent to addictive 
gambling they allow his own words to express its meaning for him: 
 
The train has left the station and I have just been served a delicious 
dinner in the café car. The train is picking up speed so I have to eat 
fast so I can finish my meal before we get to the last stop and I have 
to get off.39 
  
The Chatterjee team, and Schrag and Timble were reticent to interpret their 
patients’ artistic creativity as a pathological symptom. By the end of the 
decade, however, such clinical reticence had been overwhelmed by a neuro-
psycho-molecular diagnosis of creativity in Parkinson’s patients as a 
disabling pathology resulting from excessive dopamine levels in the VTA 
pathway producing addictive behavior. Jaime Kullisevsky, Javier 
Pagonabarraga and Merce Martinez-Corral from the University of Barcelona 
exemplify the diagnostic model of Parkinson’s creativity as addiction.40 
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Kullisevsky began by noting the earlier reports by Walker, Scharg and 
Chatterjee. But in the case they reported their patient was a forty seven year 
old amateur painter before being diagnosed with PD whose interest in art 
diminished after he was first medicated and became depressed with mild 
apathy. He retired from his employment and nothing changed in his 
behavioral profile until two years later the dopamine agonist cabergoline 
was added to his levadopa treatment. His motor symptoms significantly 
improved and he began painting again but with a dramatically changed 
attitude toward his artistic endeavor. Prior to PD he took months to 
complete a painting and his work was detailed and figurative focused on 
accurately depicting reality. Now he started to produce one painting a week 
and his paintings grew more and more impressionistic emphasizing color 
and light rather than detail. The patient explained the change as a need to 
‘express his refreshed inner emotions’. Within nine months he painted 
everyday and started showing and selling his work in local galleries in 
Barcelona.41  
Kulisevsky e.a. focused, however, on what they perceived as a 
degeneration into addiction as their patient began to continue painting 
through the night and his work pattern became disruptive to his family. 
They considered that his negative response to suggestions that he should 
stop painting was a symptom of his addiction to the activity. The patient 
regarded his art work as ‘positive for him as he was able to move more 
easily and he felt emotionally relieved’42 The Kulisevsky team added that no 
other behavioral changes occurred such as hypersexuality, domanine 
dysregulation syndrome or other impulsive behaviors. 
Because they considered the patient’s artistic focus socially disruptive 
they withdrew cabergoline over a period of six weeks during which the 
patient notably decreased his art work and became increasingly apathetic 
and depressed. They then increased levadopa but the patient did not resume 
painting. Then they decided to reinstitute cabergoline therapy at 4 mg per 
day and their patient immediately began painting again with the same 
intensity. They reduced cabergoline to 2 mg per day and he stopped 
painting at night. The clinical team believed they finally got the right therapy 
to manage what they interpreted as continuous dopaminergic stimulation 
                                                     







through dopamine agonists producing ‘a pathological usurpation of the 
neural mechanisms of creativity’.43  
Using artistic creativity production as a measure of impulsive 
predisposition in Parkinson’s patients has now become a standard 
methodology. Artistic work redefined as a Cloninger novelty seeking 
category has become firmly located within the dopaminergic pathway of 
addiction.  
The research undertaken by an international team led by Atbin Djamshidian 
from Reta Lila Western Institute and University College London 
exemplifies this.44 The Djamshidian team reported on their investigations 
the measurable ‘proneness’ of one group of PD patients over another to 
compulsive novelty seeking compared to healthy controls.45 
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Fig. 3: G.M. Spurll, ‘Zen and 
the art of painting’, Canadian 






One component of addictive proneness has been identified by Petra 
Schwingenschuh and her team at University College London and the Queen 
Square Institute as being a professional artist prior to the diagnosis of PD.46 
When pre-morbid PD patients defy the Cloninger/Menza stereotypical low 
creative, harm avoiding, unimaginative profile then they are likely to acquire 
‘Dopamine Dysregulation Syndrome’ during therapy, i.e. self-overdosing 
and strategic deception to obtain more dopamine than they needed 
according to the Schwingenschuh team. The Schwingenschuh team report 
on four patients who had all been successful visual artists before diagnosis 
who developed dopamine addiction while being treated. They explain: 
 
Artists require a certain stimulus and drive to produce new and 
creative work. In the cases described here, we suggest that the 
compulsive seeking of, and overdosing with, dopaminergic drugs 






Creativity has become disabling in the neuro-psycho-biology of novelty 
seeking as hectic pathological compulsion and addiction. The neuro-pscho-
bio narrative on Parkinson’s and creativity dramatically contrasts, however, 
with a much longer established published discourse by patients about their 
transformative experiences of illness leading to creative ways in which to 
experience what it means to be human. Parkinson’s patients’ discourses 
describe the impact of illness upon their creativity in terms of humanistic 
meaning rather than biologically coded spirituality.  
Johanne Vermette exhibited her paintings in an exhibition of 
Parkinson’s patients art and writing mounted at the McGill Centre for 
Studies in Montreal in Aging in 2001.48 Vermette was diagnosed with PD in 
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her late thirties. She is a professional artist, a mother and a physician. She 
believed that her painting style became enhanced since her diagnosis: 
 
The new style is less precise but more vibrant (…) I have a need to 
express myself more. I let myself go, sometimes painting with 
enraged fingers.49  
 
Vermette is familiar with the theoretical view about the influence of her 
medication on her imagination but she clearly doesn’t care. She perceives 
her practice of painting through the night as a way to manage the chronic 
insomnia that accompanies Parkinson’s and allows her undisturbed time 
while her children sleep. Vermette sums up the experience of enhanced 
creativity as ‘When I paint I’m in the best place, because I am only doing 
that. There’s no planning, no hierarchy of actions, but just the urgency of 
living’. Urgency to paint for Vermette is not characterized as compulsive 
addiction but rather as calming release. 
 Similarly, in contrast to creativity defined as pathologically hectic 
compulsive addiction in the neuro-psycho-molecular paradigm, Parkinson’s 
patient Gwendoline Spurll who is a hematologist at McGill University 
argues that artistic expression has given her a new Zen like quality in her life 
generally including her clinical practice often commented upon by her 
patients.50 Spurll began painting in 2003 prior to her PD diagnosis when she 
focused on expressing the desolation she had felt during a period of her life 
twenty years earlier while struggling with infertility. Following her diagnosis 
of PD in 2005 she started to focus on the dialectics of joy and dismay.51  
Dismay that her Parkinson’s will one day force her to end her clinical 
career and probably leave her home and joy that she will at least be able to 
continue to paint probably throughout the duration of her degenerative 
condition:  
 
Does painting affect my practice as a physician’, Spurll asks. ‘I think 
so. My patients often describe my bedside manner as ‘calm, even 
Zen.52 
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Spurll accounts for this as a sort of transference of her own experience in 
sitting down with a blank canvass and starting to paint. For her it induces, ‘a 
calm state in my mind that removes me from the imperfections of my life –  
and it convinces me that patients can likewise accept whatever confronts 
them. Apparently this conviction is communicated to my patients through 
my calmness’.53 
 
Spurll reflects on the relationship of the onset of Parkinson’s and the 
emergence of her creative interest in painting. Citing Sacks discussion of the 
disruption of self-expression inhibition in neurological patients with Frontal 
Lobe lesions such as Frontal Lobe Dementia she ponders whether this 
effect noted in Parkinson’s patients may also be happening to herself. 
‘What does this mean?’ Spurll asks, ‘I don’t know’. What she does know is 
that painting ‘induces a flow state, and removes from my consciousness the 
constant knowledge of my physical limitations. It is like a meditation. It is 
my Zen’.54 
 A comparable patient experience was reported by Georg 
Ebersback, at the Beelitz-Heilstatten Parkinson’s Institute in Germany, of a 
61 year old woman who created a series of abstracted colored photographs 
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to express the meaning and help her manage hallucinations produced by her 
Parkinson’s drug therapy.55 
 For Alan Babbitt, however, the relationship between his Parkinson 
disease and his creativity has nothing to do with therapeutics.56 For Babbitt 
Parkinson’s became an opportunity in much the same way as Henry Matisse 
described the impact of illness upon his artistic life-world over a century 
ago. For Babbitt PD stimulated the creation of an entirely new artistic genre 
which he calls Tremor Enhanced Photography.57  
Babbitt has been a locally renowned San Francisco Bay Area Artist 
since the 1970s. And his initial interest in photography stemmed from the 
transformative visual experience it gave him having impaired vision from 
albinism, nystagmus, lazy-eye and profound myopia. When his mother and 
father gave him a Brownie Hawkeye camera at the age of seven for the first 
time he could see details close-up. Babbitt describes something far more 
profound, however, than just being liberated from his myopia:  
 
But then I discovered I could use it [photography] to see things 
people with good vision couldn’t. Now that was satisfying! Turns 
out the truth is, when it comes to photography how well you see 
has only a little to do with how well you ‘see’. 58 
  
Babbitt makes fun of his ‘addiction’ to photography admitting to becoming 
shamelessly ‘high’ on it, breaking trespass laws and getting a paper round in 
order to feed his habit. When the movement disorders of Parkinson’s began 
to appear in 2003 for the first time ‘darkness filled my viewfinder’. He lost 
interest in photography, rarely venturing out to shoot and bored with the 
results. One night on the Las Vegas Strip, ‘of all places’ he says in disbelief, 
‘I began to see the light (…) I began to let the tremor have its way as I 
clicked the shutter.’ 
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 The experience was, ‘Whoa!!!’ ‘The visual gumbo of flashing lights, 
muli-tinted neon and watery reflections became wonderful smears, blurs 
and streaks of color. Now THIS was fun!’59 
 Beyond the sheer exuberance of the work Babbitt describes an 
epistemological shift of understanding photography and PD.  
‘Liberated from the photo dogma of ‘still’ness and sharpness, I’ve 
experienced a rush of creative freedom like never before. Rules? Who needs 






I have argued that a behavioral paradigm of a genetically determined 
Parkinson’s personality developed from the end of the twentieth century 
which identified the existence of pre-morbid patients with symptomatic low 
creativity and high harm avoidance using Cloninger [and Cloninger’s 
subsequently derived] psychobiological dopaminergic measurement. As a 
result, when the genetically predisposed low creativity paradigm of the 
Parkinson’s personality is disrupted by artistic expression in patients, 
creativity is redefined neuromolecularly as a pathological symptom of 
excessive dopamine stimulation and addiction.  
Finally I have argued that the neuromolecular psychobiological 
characterization of the relationship between creativity and Parkinson’s 
patients has a counter culture represented in the discourses articulated by 
patients of their experiences. In patient narratives, replacing ontological 
stasis with emergence changes the relationship between embodiment and 
becoming. As a result sufferers have changed the material experience of 
disability by creating the meaning of shifting embodiments for themselves 
and others. For example, by engaging, expressing and disseminating the 
dialectics of dread and subliminal exquisiteness through artistic work, 
unfolding the consequences of the mis-folding proteins that are causing 
their degenerative physical change.   
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If the meaning of disablement is disembodied then the essentialism 
of stigma – including the stigma of objectified pity might also be 
undermined. In Parkinson’s patients’ accounts of their experience of 
creativity, the doyen of disability theory, Paul Longmore’s, vision of a new 
epistemology of ability becomes a material possibility.61 For Parkinson’s 
patients engaged in creative artistic work the essentialist concept of 
disability disappears into limitless opportunities for creating meaning not 
out of being but out of incessantly becoming human. And here, perhaps, 
the contemporary focus of post-humanist theory on emergent ontology may 
be of some interpretive value.62 If post humanist theory has any value for 
interpreting the history of Parkinson’s disease it is that it interrogates the 
stifling suffocating stability of the conceptualization of humanness in 
humanism.63 If troubling ontology with emergent becoming can disrupt 
cultural essentialisms regarding Parkinson’s disease then perhaps such 
ideational shifts can impact the clinical encounter in which it is defined and 
managed. Perhaps undermining cultural essentialisms and scientific 
reductionism might lend legitimacy to a broader expansive therapeutic 
creativity. In such a self-reflective clinical imaginary, counter intuitive 
therapeutics may garner less ridicule and gain more traction such as 
encouraging people with motor disorders to dance as prefigured by the 
Leonard Lowe character in Awakenings. Only this time the therapeutic 
treatment which is currently being reported in the clinical literature, is 
specifically the Tango cure for retropulsive gaits.64 
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